We inform healthcare professionals of the recent campaign to promote awareness of the risk and new resources available to support safe use following previous advice to health and care professionals.
Published: 2021-05-20T11:04:42Z
If a patient reports persistent symptoms when switching between different levothyroxine tablet formulations, consider consistently prescribing a specific product known to be well tolerated by the patient. If symptoms or poor…
Published: 2021-05-19T12:57:47Z
A summary of advice recently issued by the MHRA relating to coronavirus (COVID-19), up to 13 May 2021.
Published: 2021-05-19T12:57:38Z
A summary of letters and recent medicine recalls and notifications sent to healthcare professionals.
Published: 2021-05-19T12:57:21Z
Addition of a polyethylene glycol (PEG)-based laxative to a liquid that has been thickened with a starch-based thickener may counteract the thickening action, placing patients with dysphagia at a greater risk of aspiration.
Published: 2021-04-27T13:23:03Z
A summary of advice recently issued by the MHRA relating to coronavirus (COVID-19), up to 21 April 2021.
Published: 2021-04-27T13:22:44Z
A summary of letters and recent medicine recalls and notifications sent to healthcare professionals.
Published: 2021-04-27T13:22:10Z
Periodically perform skin examinations in patients on bendamustine-containing regimens and consider PML in the differential diagnosis for patients on bendamustine with new or worsening neurological, cognitive, or behavioural…
Published: 2021-03-24T14:27:55Z
A summary of advice recently issued by the MHRA relating to coronavirus (COVID-19), up to 18 March 2021.
Published: 2021-03-24T14:27:49Z
A summary of letters and drug alerts recently sent to healthcare professionals.
Published: 2021-03-24T14:27:38Z